北美非处方药和膳食补充剂市场预测至 2027 年 - COVID-19 影响和按产品划分的区域分析(咳嗽和感冒产品、维生素和膳食补充剂、镇痛药、胃肠道产品、助眠剂、口腔护理产品、眼科产品、抗酸剂、女性用药)护理及其他);类型(品牌和通用);剂型(片剂、胶囊、粉剂、软膏、液体等);分销渠道(医院和零售药店、零售店、在线渠道等)和地理位置

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 198    |    Report Code: TIPRE00013996    |    Category: Life Sciences

North America OTC Drug and Dietary Supplement Market

市场介绍

非处方药 (OTC) 可供公众购买一般使用。这些药物不需要医生处方。非处方药可用于治疗因疾病引起的各种医学症状,例如咳嗽和感冒、腹泻、胃灼热、便秘、痤疮、疼痛等。另一方面,出于健身目的,膳食补充剂可以在柜台购买。然而,在某些情况下,当一个人病危或需要治疗时,购买含有药物成分的膳食补充剂需要医生的处方。这些非处方药和营养补充剂有两种类型,例如品牌药或仿制药。

市场概况和动态

北美非处方药和膳食补充剂市场预计将从 2019 年的 1318.183 亿美元增至 2027 年的 2243.495 亿美元。该市场预计将以 7.0 的复合年增长率增长%从2020年到2027年。推动市场增长的因素包括人们对一般健康问题的认识不断提高,预计非处方药的优势将推动市场的增长。然而,FDA对非处方药的严格监管是阻碍市场增长的主要因素。新冠病毒(COVID19)影响了北美国家,导致大量冠状病毒病例。人们正在购买市场上更多的免疫力增强产品来对抗冠状病毒的影响

主要细分市场

从产品来看,2019年镇痛药市场份额最大;然而,预计维生素和膳食补充剂领域在预测期内将达到市场上最高的复合年增长率。就类型而言,仿制药细分市场在 2019 年占据了较大的市场份额,预计类似细分市场在预测期内将占据更高的市场份额。同样,就形式而言,平板电脑细分市场在 2019 年占据了更大的市场份额,预计在预测期内市场复合年增长率将更高。就分销渠道而言,医院和零售药店在 2019 年占据最大市场份额:然而,预计在线渠道领域在预测期内的复合年增长率最高。

<强>主要来源和列出的公司

世界卫生组织 (WHO)、世界心脏联合会、国家心脏中心生物技术信息是报告中包含的北美非处方药和膳食补充剂市场的一些主要一手和二手来源。

购买该产品的理由报告

  • 了解北美非处方药和膳食补充剂市场格局,并确定最有可能保证强劲的细分市场return
  • 了解北美非处方药和膳食补充剂市场不断变化的竞争格局,保持领先地位
  • 通过确定最有可能销售前景的细分市场,有效规划北美非处方药和膳食补充剂市场的并购和合作交易
  • 帮助掌握知识通过对北美非处方药和膳食补充剂市场各个细分市场表现的敏锐和全面分析来做出业务决策
  • 获得2019年至2027年各个细分市场的市场收入预测该地区

北美非处方药和膳食补充剂市场细分

非处方药和膳食补充剂–按产品分类

  • 咳嗽和感冒产品
  • 维生素和膳食补充剂
  • 镇痛药
  • 胃肠产品
  • 助眠剂
  • 口腔护理产品
  • 眼科产品
  • 抗酸剂
  • 女性护理
  • 其他

 

非处方药和膳食补充剂–按类型

  • 品牌
  • 仿制药

 

非处方药和膳食补充剂–按剂型

  • 片剂
  • 胶囊
  • 粉剂
  • 软膏
  • 液体
  • < li>其他

非处方药和膳食补充剂 -按分销渠道

  • 医院和零售药店
  • 零售店
  • 在线渠道
  • 其他

按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

 < /strong>

公司简介

  • 葛兰素史克公司
  • 赛诺菲
  • 强生公司Services, Inc.
  • 雅培
  • 艾伯维公司
  • Bausch Health Companies Inc.
  • 拜耳公司
  • 宝洁公司赌博
  • 诺华公司
  • 利洁时集团有限公司


North America OTC Drug and Dietary Supplement Strategic Insights

Strategic insights for North America OTC Drug and Dietary Supplement involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-otc-drug-and-dietary-supplement-market-strategic-framework.webp
Get more information on this report

North America OTC Drug and Dietary Supplement Report Scope

Report Attribute Details
Market size in 2019 US$ 131,818.3 Million
Market Size by 2027 US$ 224,349.5 Million
Global CAGR (2020 - 2027) 7.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 咳嗽和感冒产品
  • 维生素和膳食补充剂
  • 止痛药
  • 胃肠道产品
  • 助眠剂
  • 口腔护理产品
  • 眼科产品
  • 抗酸药
  • 女性护理
By 类型
  • 品牌和通用
By 剂型
  • 片剂
  • 胶囊
  • 粉剂
  • 软膏
  • 液体
By 分销渠道
  • 医院和零售药店
  • 零售店
  • 在线渠道
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Abbott
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Procter & Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc
  • Get more information on this report

    North America OTC Drug and Dietary Supplement Regional Insights

    The regional scope of North America OTC Drug and Dietary Supplement refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-otc-drug-and-dietary-supplement-market-geography.webp
    Get more information on this report

    The List of Companies - North America OTC Drug and Dietary Supplement Market

    The List of Companies - North America OTC Drug and Dietary Supplement Market

    1. GlaxoSmithKline plc.
    2. Sanofi
    3. Johnson and Johnson Services, Inc.
    4. Abbott
    5. AbbVie Inc.
    6. Bausch Health Companies Inc.
    7. Bayer AG
    8. Procter & Gamble
    9. Novartis AG
    10. Reckitt Benckiser Group Plc

     

    Frequently Asked Questions
    How big is the North America OTC Drug and Dietary Supplement Market?

    The North America OTC Drug and Dietary Supplement Market is valued at US$ 131,818.3 Million in 2019, it is projected to reach US$ 224,349.5 Million by 2027.

    What is the CAGR for North America OTC Drug and Dietary Supplement Market by (2020 - 2027)?

    As per our report North America OTC Drug and Dietary Supplement Market, the market size is valued at US$ 131,818.3 Million in 2019, projecting it to reach US$ 224,349.5 Million by 2027. This translates to a CAGR of approximately 7.0% during the forecast period.

    What segments are covered in this report?

    The North America OTC Drug and Dietary Supplement Market report typically cover these key segments-

  • 产品 (咳嗽和感冒产品, 维生素和膳食补充剂, 止痛药, 胃肠道产品, 助眠剂, 口腔护理产品, 眼科产品, 抗酸药, 女性护理)
  • 类型 (品牌和通用)
  • 剂型 (片剂, 胶囊, 粉剂, 软膏, 液体)
  • What is the historic period, base year, and forecast period taken for North America OTC Drug and Dietary Supplement Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America OTC Drug and Dietary Supplement Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America OTC Drug and Dietary Supplement Market?

    The North America OTC Drug and Dietary Supplement Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Abbott
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Procter & Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc
  • Who should buy this report?

    The North America OTC Drug and Dietary Supplement Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America OTC Drug and Dietary Supplement Market value chain can benefit from the information contained in a comprehensive market report.